These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 22108447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial.
    Tunggal P, Ng FH, Lam KF, Chan FK, Lau YK.
    Am Heart J; 2011 Nov; 162(5):870-4. PubMed ID: 22093203
    [Abstract] [Full Text] [Related]

  • 3. [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
    Johansen M.
    Tidsskr Nor Laegeforen; 2006 Nov 02; 126(21):2802-4. PubMed ID: 17086221
    [Abstract] [Full Text] [Related]

  • 4. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH, Wong SY, Lam KF, Chang CM, Lau YK, Chu WM, Wong BC.
    Am J Gastroenterol; 2008 Apr 02; 103(4):865-71. PubMed ID: 18177451
    [Abstract] [Full Text] [Related]

  • 5. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hung WK, Loo CK, Hu WH, Chan AO, Kwok KF, Fung TT, Wong J, Lam SK.
    Clin Gastroenterol Hepatol; 2006 Jul 02; 4(7):860-5. PubMed ID: 16797240
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice.
    Heer T, Juenger C, Gitt AK, Bauer T, Towae F, Zahn R, Senges J, Zeymer U, Acute Coronary Syndromes (ACOS) Registry Investigators.
    J Thromb Thrombolysis; 2009 Oct 02; 28(3):325-32. PubMed ID: 19101783
    [Abstract] [Full Text] [Related]

  • 7. Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
    Yano H, Tsukahara K, Morita S, Endo T, Sugano T, Hibi K, Himeno H, Fukui K, Umemura S, Kimura K.
    Circ J; 2012 Oct 02; 76(11):2673-80. PubMed ID: 22864179
    [Abstract] [Full Text] [Related]

  • 8. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
    Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ.
    N Engl J Med; 2005 Jan 20; 352(3):238-44. PubMed ID: 15659723
    [Abstract] [Full Text] [Related]

  • 9. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP, COGENT Investigators.
    J Am Coll Cardiol; 2016 Apr 12; 67(14):1661-71. PubMed ID: 27012778
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW, Wen YW, Huang WF, Chen PF, Kuo KN, Hsiao FY.
    J Gastroenterol; 2011 Jan 12; 46(1):39-45. PubMed ID: 20811753
    [Abstract] [Full Text] [Related]

  • 11. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK, Kyaw M, Tanigawa T, Higuchi K, Fujimoto K, Cheong PK, Lee V, Kinoshita Y, Naito Y, Watanabe T, Ching JY, Lam K, Lo A, Chan H, Lui R, Tang RS, Sakata Y, Tse YK, Takeuchi T, Handa O, Nebiki H, Wu JC, Abe T, Mishiro T, Ng SC, Arakawa T.
    Gastroenterology; 2017 Jan 12; 152(1):105-110.e1. PubMed ID: 27641510
    [Abstract] [Full Text] [Related]

  • 12. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P, Udell JA, Murphy SA, Cannon CP, Antman EM, Braunwald E, Wiviott SD.
    J Am Coll Cardiol; 2014 Jan 28; 63(3):225-32. PubMed ID: 24140678
    [Abstract] [Full Text] [Related]

  • 13. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
    Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF, DISPERSE-2 Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1844-51. PubMed ID: 17980250
    [Abstract] [Full Text] [Related]

  • 14. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
    Roe MT, Goodman SG, Ohman EM, Stevens SR, Hochman JS, Gottlieb S, Martinez F, Dalby AJ, Boden WE, White HD, Prabhakaran D, Winters KJ, Aylward PE, Bassand JP, McGuire DK, Ardissino D, Fox KA, Armstrong PW.
    Circulation; 2013 Aug 20; 128(8):823-33. PubMed ID: 23852610
    [Abstract] [Full Text] [Related]

  • 15. Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.
    Lozano I, Sanchez-Insa E, de Leiras SR, Carrillo P, Ruiz-Quevedo V, Pinar E, Gopar-Gopar S, Bayon J, Mañas P, Lasa G, CruzGonzalez I, Hernandez F, Fernandez-Portales J, Fernandez-Fernandez J, Pérez-Serradilla A, de la Torre Hernandez JM, Gomez-Jaume A.
    Am J Cardiol; 2016 Feb 01; 117(3):366-8. PubMed ID: 26708640
    [Abstract] [Full Text] [Related]

  • 16. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Ng FH, Wong SY, Lam KF, Chu WM, Chan P, Ling YH, Kng C, Yuen WC, Lau YK, Kwan A, Wong BC.
    Gastroenterology; 2010 Jan 01; 138(1):82-8. PubMed ID: 19837071
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
    Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Bhatt DL, COGENT Investigators.
    Am J Med; 2016 Sep 01; 129(9):1002-5. PubMed ID: 27143321
    [Abstract] [Full Text] [Related]

  • 18. The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention.
    Wu Y, Chen C, Luo Y, Yu W, Huang S, Lin D.
    Adv Clin Exp Med; 2019 Nov 01; 28(11):1519-1524. PubMed ID: 31660706
    [Abstract] [Full Text] [Related]

  • 19. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
    Liberopoulos EN, Elisaf MS, Tselepis AD, Archimandritis A, Kiskinis D, Cokkinos D, Mikhailidis DP.
    Platelets; 2006 Feb 01; 17(1):1-6. PubMed ID: 16308180
    [Abstract] [Full Text] [Related]

  • 20. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.
    Clin Ther; 2009 Sep 01; 31(9):2038-47. PubMed ID: 19843493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.